Clinical impact of genetic polymorphisms of vascular endothelial related in Japanese metastatic renal cell carcinoma patients treated with axitinib

被引：0
|
作者：
Numakura, Kazuyuki [1 ]
Igarashi, Ryoma [1 ]
Nara, Taketoshi [1 ]
Kanda, Sohei [1 ]
Tsuruta, Hiroshi [1 ]
Huang, Mingguo [1 ]
Saito, Mitsuru [1 ]
Narita, Shintaro [1 ]
Inoue, Takamitsu [1 ]
Satoh, Shigeru [2 ]
Niioka, Takenori [3 ]
Miura, Masatomo [3 ]
机构：
[1] Akita Univ, Grad Sch Med, Akita, Japan
[2] Akita Univ Hosp, Ctr Kidney Dis & Transplantat, Akita, Japan
[3] Akita Univ Hosp, Dept Pharm, Akita, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2018年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
IS-66
引用
收藏
页码：229 / 229
页数：1
相关论文
共 50 条
  • [31] Drug Holiday in Metastatic Renal-Cell Carcinoma Patients Treated With Vascular Endothelial Growth Factor Receptor Inhibitors
    Mittal, Kriti
    Derosa, Lisa
    Albiges, Laurence
    Wood, Laura
    Elson, Paul
    Gilligan, Timothy
    Garcia, Jorge
    Dreicer, Robert
    Escudier, Bernard
    Rini, Brian
    CLINICAL GENITOURINARY CANCER, 2018, 16 (03) : E663 - E667
  • [32] Efficacy of axitinib in patients with metastatic renal cell carcinoma previously treated with both VEGFR-TKI and mTORI
    Mizuno, Ryuichi
    Kosaka, Takeo
    Mikami, Shuji
    Oya, Mototsugu
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [33] An individualized dose titration schedule of axitinib in patients with metastatic renal cell carcinoma
    Allman, Kimberly
    Garcia, Jorge A.
    Grivas, Petros
    Gilligan, Timothy
    Martin, Allison
    Beach, Jennifer
    Wood, Laura
    Zanick, Beth
    Rini, Brian I.
    BJU INTERNATIONAL, 2015, 116 : 2 - 2
  • [34] Five-Year Survival in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma Treated With Axitinib
    Rini, Brian I.
    Rouge, Thibault de La Motte
    Harzstark, Andrea L.
    Michaelson, M. Dror
    Liu, Glenn
    Gruenwald, Viktor
    Ingrosso, Antonella
    Tortorici, Michael A.
    Bycott, Paul
    Kim, Sinil
    Bloom, Joanna
    Motzer, Robert J.
    CLINICAL GENITOURINARY CANCER, 2013, 11 (02) : 107 - 114
  • [35] Thyroid Dysfunction in Patients Treated with Tyrosine Kinase Inhibitors, Sunitinib, Sorafenib and Axitinib, for Metastatic Renal Cell Carcinoma
    Daimon, Makoto
    Kato, Tomoyuki
    Kaino, Wataru
    Takase, Kaoru
    Karasawa, Shigeru
    Wada, Kiriko
    Kameda, Wataru
    Susa, Shinji
    Oizumi, Toshihide
    Tomita, Yoshihiko
    Kato, Takeo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (08) : 742 - 747
  • [36] EXOSOMAL MIRNAS AND SERUM CYTOKINES AS PREDICTORS FOR TREATMENT OUTCOMES IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH AXITINIB
    Suzuki-Honma, Naoko
    Tsuchiya, Norihiko
    Inoue, Takamitsu
    Narita, Shintaro
    Saito, Mitsuru
    Tsuruta, Hiroshi
    Maeno, Atsushi
    Satoh, Shigeru
    Habuchi, Tomonori
    JOURNAL OF UROLOGY, 2016, 195 (04): : E322 - E323
  • [37] Re: Efficacy and Safety of Axitinib in Elderly Patients with Metastatic Renal Cell Carcinoma
    Griebling, Tomas L.
    JOURNAL OF UROLOGY, 2017, 197 (02): : 316 - 317
  • [38] Axitinib-induced proteinuria and efficacy in patients with metastatic renal cell carcinoma
    Nozawa, Masahiro
    Sugimoto, Koichi
    Ohzeki, Takayuki
    Minami, Takafumi
    Shimizu, Nobutaka
    Adomi, Shogo
    Saito, Yoshitaka
    Nose, Kazuhiro
    Yoshimura, Kazuhiro
    Uemura, Hirotsugu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (04) : 748 - 755
  • [39] Response to post-axitinib treatment in patients with metastatic renal cell carcinoma
    Namita Chittoria
    Housam Haddad
    Paul Elson
    Nizar M. Tannir
    Laura S. Wood
    Robert Dreicer
    Jorge A. Garcia
    Brian I. Rini
    Eric Jonasch
    BMC Cancer, 16
  • [40] Efficacy of axitinib in patients with metastatic renal cell carcinoma refractory to nivolumab therapy
    Yoshida, Kazuhiko
    Takagi, Toshio
    Kondo, Tsunenori
    Kobayashi, Hirohito
    Iizuka, Junpei
    Fukuda, Hironori
    Ishihara, Hiroki
    Okumi, Masayoshi
    Ishida, Hideki
    Tanabe, Kazunari
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (06) : 576 - 580
12345